USING GENOMIC SIGNATURES TO PREDICT COMBINATION THERAPY IN GBM

PIs: John H. Sampson, M.D., Ph.D., M.H.Sc.
Associate Professor of Surgery
Associate Deputy Director
Preston Robert Tisch Brain Tumor Center at Duke

Joseph R. Nevins, Ph.D.
Barbara Levine Professor of Cancer Genomics
Director Center for Applied Genomics & Technology
Duke Institute for Genome Sciences & Policy

Close Menu